Forian Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.25
- Today's High:
- $2.35
- Open Price:
- $2.3001
- 52W Low:
- $2
- 52W High:
- $5.445
- Prev. Close:
- $2.31
- Volume:
- 5250
Company Statistics
- Market Cap.:
- $76.56 million
- Book Value:
- 0.656
- Revenue TTM:
- $30.63 million
- Operating Margin TTM:
- -48.8%
- Gross Profit TTM:
- $21.13 million
- Profit Margin:
- -10.8%
- Return on Assets TTM:
- -17.65%
- Return on Equity TTM:
- -78.28%
Company Profile
Forian Inc had its IPO on 2021-03-03 under the ticker symbol FORA.
The company operates in the Healthcare sector and Health Information Services industry. Forian Inc has a staff strength of 102 employees.
Stock update
Shares of Forian Inc opened at $2.3 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.25 - $2.35, and closed at $2.25.
This is a -2.6% slip from the previous day's closing price.
A total volume of 5,250 shares were traded at the close of the day’s session.
In the last one week, shares of Forian Inc have slipped by -4.26%.
Forian Inc's Key Ratios
Forian Inc has a market cap of $76.56 million, indicating a price to book ratio of 5.6563 and a price to sales ratio of 2.7077.
In the last 12-months Forian Inc’s revenue was $30.63 million with a gross profit of $21.13 million and an EBITDA of $-12575992. The EBITDA ratio measures Forian Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Forian Inc’s operating margin was -48.8% while its return on assets stood at -17.65% with a return of equity of -78.28%.
In Q2, Forian Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 35.8%.
Forian Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.47 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Forian Inc’s profitability.
Forian Inc stock is trading at a EV to sales ratio of 3.3282 and a EV to EBITDA ratio of -3.2256. Its price to sales ratio in the trailing 12-months stood at 2.7077.
Forian Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $55.35 million
- Total Liabilities
- $9.03 million
- Operating Cash Flow
- $2.34 million
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Forian Inc ended 2024 with $55.35 million in total assets and $0 in total liabilities. Its intangible assets were valued at $55.35 million while shareholder equity stood at $20.79 million.
Forian Inc ended 2024 with $0 in deferred long-term liabilities, $9.03 million in other current liabilities, 32452.00 in common stock, $-53416448.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.90 million and cash and short-term investments were $41.25 million. The company’s total short-term debt was $20,836 while long-term debt stood at $25.53 million.
Forian Inc’s total current assets stands at $55.07 million while long-term investments were $0 and short-term investments were $38.34 million. Its net receivables were $12.15 million compared to accounts payable of $921542.00 and inventory worth $968130.00.
In 2024, Forian Inc's operating cash flow was $2.34 million while its capital expenditure stood at $0.
Comparatively, Forian Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $2.25
- 52-Week High
- $5.445
- 52-Week Low
- $2
- Analyst Target Price
- $5
Forian Inc stock is currently trading at $2.25 per share. It touched a 52-week high of $5.445 and a 52-week low of $5.445. Analysts tracking the stock have a 12-month average target price of $5.
Its 50-day moving average was $2.55 and 200-day moving average was $2.87 The short ratio stood at 68.64 indicating a short percent outstanding of 0%.
Around 4607.2% of the company’s stock are held by insiders while 1266.9% are held by institutions.
Frequently Asked Questions About Forian Inc
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company’s products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.